Protalix Biotherapeutics, Inc. (de) · AMEX:PLX
MAK Capital Fund LP reported a 5.80% stake in Protalix Biotherapeutics, Inc. (de) (Schedule 13G)
Event Feb 26, 2026 · Filed Mar 4, 2026
MAK Capital Fund LP reported a 5.80% stake in Protalix Biotherapeutics, Inc. (de), 4,649,599 shares, as a passive investor on Feb 26, 2026. Filed Mar 4, 2026 (Schedule 13G).
- Stake
- 5.80%
- Shares
- 4,649,599
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| MAK Capital Fund LP | 5.80% | 4,649,599 |
| MAK CAPITAL ONE LLC | 5.80% | 4,649,599 |
| Kaufman Michael A | 5.80% | 4,649,599 |